Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma
- 1 September 1992
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 14 (1) , 63-72
- https://doi.org/10.1007/bf00170946
Abstract
We attempted to show a dose effect relationship for radiation therapy by treating patients harbouring malignant glioma with increasing doses of radiation in a step-wise fashion. We postulated that no increase in delayed toxicity would be seen because we used hyperfractionation technique. Between January 1981 and December 1988 we treated 280 patients three times daily at 4 hour intervals. 100 patients received a total dose of 6141 cGy, 73 patients received 7120 cGy, and 107 patients received 8000 cGy. CCNU was given at the time of tumor progression following radiotherapy. Median time to tumor progression was 28 weeks for patients who received 6141 cGy, 27 weeks for patients who received 7120 cGy and 36 weeks for patients who received 8000 cGy. Median survival was 46 weeks for patients who received 6141 cGy, 38 weeks for patients who received 7120 cGy and 45 weeks for patients who received 8000 cGy. There was no statistically significant difference in either time to tumor progression or survival among the three treatment arms and no dose response effect was seen. There was no increase in delayed radiation toxicity when the total radiation dose was increased up to 8000 cGy.Keywords
This publication has 17 references indexed in Scilit:
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Selection bias in clinical trails of anaplastic gliomaAnnals of Neurology, 1989
- A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG studyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Misonidazole combined with hyperfractionation in the management of malignant gliomaInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Accelerated fractionation vs hyperfractionation: Rationales for several treatments per dayInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trialCancer, 1982
- HyperfractionationInternational Journal of Radiation Oncology*Biology*Physics, 1982
- High dose radiation therapy in the treatment of malignant gliomas: Final ReportInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Cell Cycle Redistribution as a Factor in Multifraction IrradiationRadiology, 1975
- A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.1965